Cargando…
Breast density predicts endocrine treatment outcome in the adjuvant setting
In their report, Kim and colleagues study the ability of changes in mammographic density over a period of 12 to 18 months to predict subsequent recurrence in 1,065 Korean women with oestrogen receptor-positive breast cancer. Based on 80 recurrences, a clear gradient for lower recurrence rates was se...
Autor principal: | Cuzick, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680935/ https://www.ncbi.nlm.nih.gov/pubmed/22889086 http://dx.doi.org/10.1186/bcr3235 |
Ejemplares similares
-
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
por: Sestak, Ivana, et al.
Publicado: (2019) -
Preventing invasive breast cancer using endocrine therapy
por: Thorat, Mangesh A., et al.
Publicado: (2017) -
Bone versus breast density
por: Cuzick, Jack
Publicado: (2006) -
Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006) -
Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress
por: Ganz, Patricia A
Publicado: (2016)